Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.5 USD | +0.19% | -5.69% | +24.36% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- With an expected P/E ratio at 50.67 and 30.31 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Multiline Insurance & Brokers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+24.36% | 6.36B | - | ||
+1.36% | 63.86B | C | ||
+15.12% | 55.97B | B- | ||
+6.10% | 26.3B | C+ | ||
+27.23% | 25.56B | C | ||
+11.09% | 7.96B | - | ||
-5.93% | 4B | B | ||
0.00% | 3.7B | - | - | |
+11.71% | 2.4B | C+ | ||
+42.63% | 2.25B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- RYAN Stock
- Ratings Ryan Specialty Holdings, Inc.